BACKGROUND: With the number of cancer survivors increasing, follow-up care to deal with problems related to their original cancer is needed. One of these is screening for a second primary cancer as cancer survivors are one of the high-risk groups for cancer occurrence. The purpose of this study was to assess the screening rates of major cancers in patients with a history of cancer in Korea. METHODS: Our data were from the 4th Korea National Health and Nutrition Examination Survey. We narrowed the data to include 11,169 adults aged 40 and 80 years. Participants were grouped according to their history of cancer and the time since cancer diagnosis into no cancer group (no cancer diagnosis), cancer survivor group (cancer diagnosis > or =5 years ago), and cancer follow-up group (cancer diagnosis <5 years ago). We estimated the screening acceptance rates of major cancers according to the cancer history and assessed the relationships between them. RESULTS: The cancer screening rates of stomach, breast, cervix, and colon were 42.4+/-4.9%, 45.5+/-5.6%, 42.1+/-6.4%, and 24.1+/-3.8% for the cancer survivor group and 45.6+/-5.2%, 61.9+/-6.2%, 48.8+/-7.0%, and 20.8+/-4.3% for the cancer follow-up group. A history of cancer diagnosis was not related to the acceptance rate of stomach and cervical cancer screening. Breast cancer screening (odd ratio [OR], 1.783; 95% confidence interval [CI], 1.044-3.048) increased only in the cancer follow-up group. At 5 years after a cancer diagnosis, only the screening rate for colon cancer (OR, 1.701; 95% CI, 1.119-2.588) persistently increased compared to individuals without a history of cancer. CONCLUSIONS: The screening for breast cancer was the only screening examination whose rate increased in the cancer follow-up group, with the significance disappearing in the cancer survivor group. Our results demonstrate that the screening rate for secondary cancers is below optimal in cancer patients in Korea.
Adult* ; Breast ; Breast Neoplasms ; Cervix Uteri ; Colon ; Colonic Neoplasms ; Diagnosis* ; Early Detection of Cancer ; Female ; Follow-Up Studies ; Humans ; Korea* ; Mass Screening* ; Neoplasms, Second Primary ; Nutrition Surveys ; Stomach ; Survivors ; Uterine Cervical Neoplasms

OBJECTIVE: Neonatal blood pressure is one of the vital signs used to assess the general health of a newborn infant. But, it is difficult to measure and varies according to the model of sphygmomanometer, the used method, the postconceptional age, birth weight, asphyxia, postnatal age and activity. We have assessed the rnean value of blood pressure(BP) according to postconceptional age. Variations caused by the postconceptional age, birth weight, body surface area(BSA), postnatal age, and sex were analyzed to determine the rnost important factor influencing the neonatal BP. METHODS: This study included 448 normal fullterm infants and healthy preterm infants born from Jan. 1995 to Aug. 1997 at Ewha Dongdaemoon and Mokdong Hospital. The BP was taken on day 1, 3, 5 with the oscillometric device(Dinamap 1846 critikon Inc.), for premature infants BP was followed up every week afterward. RESULTS: The neonatal BP was related to the postconceptional age(R=0.204, P<0.05), BSA(R =0.191, P<0.05), birth weight(R=0.183, P<0.05) and the postnatal age in fullterm infants(R=0.022, P<0.05) but not with the sex of the infant. The postconceptional age was the most significant variable among those influencing the BP. The normal value of the systolic and the diastolic BP was expressed as mean+/-2SD according to the postconceptional age, less than 28 weeks(n=27) systolic/diastolic pressure 50.4+/-23.1mmHg/26.2+/-12.8mmHg, 28-32weeks(n= 63) 60.1+/- 30.6mmHg/33.6+/-16.7mmHg, 32-36weeks(n = 139) 63.2+/- 20.4mmHg/37.7+/- 19.8 mmHg, 36- 40weeks(n=543) 65.6+/-18.5mmHg/38.6+/-17.3mmHg, more than 40weeks(n= 136) 67.7+/-16,9mmHg/39.3+/- 15.8mmHg. The increase in blood prssure with the postconceptional age was statistically significant. CONCLUSION: The normal range of neonatal BP, especially preterm infants, was presented, and it would be much valuable for the evaluation of BP in neonate if standardized by postconceptional age.
Asphyxia ; Birth Weight ; Blood Pressure* ; Humans ; Infant ; Infant, Newborn ; Infant, Premature ; Parturition ; Reference Values* ; Sphygmomanometers ; Vital Signs

Purpose: : The purpose of this study is to identify the prevalence of stroke and related factors and thereby to provide fundamental data for the prevention and management of stroke. Methods : This study is a secondary analysis based on the raw data from the Korea National Health and Nutrition Examination Survey (KNHANES) for the years 2011 and 2021. The subjects of the study were 5,350 people in 2011 and 4,687 people in 2021 aged 30 years and older. Analysis method was frequency analysis, complex samples Chi-square test, complex samples logistic regression analysis. Results : In 2011, the factors associated with stroke prevalence were gender, age, hypertension, dyslipidemia, diabetes, maternal diabetes, subjective health conditions, depressed more than 2 weeks, activity limitations, drinking, and Stress recognition. In 2021, the factors included age, hypertension, dyslipidemia, diabetes, paternal hyperlipidemia, maternal stroke, paternal diabetes, subjective health conditions, depressed more than 2 weeks, activity limitations, smoking present, and Stress recognition. Conclusion : To control the factors related to stroke prevalence, it is necessary to make active interventions for hypertension, dyslipidemia, and diabetes, such as medical treatment at healthcare institutions and individual treatment and preventive activities. Additionally, it is necessary to apply age-specific management programs, participate in health management programs, and receive psychological counseling to manage health related factors. Individuals, who have parental history of hypertension, stroke, hyperlipidemia, or diabetes, should receive selective screening and actively manage health behaviors and dietary habits in order to prevent stroke.

Purpose: : The purpose of this study is to identify the prevalence of stroke and related factors and thereby to provide fundamental data for the prevention and management of stroke. Methods : This study is a secondary analysis based on the raw data from the Korea National Health and Nutrition Examination Survey (KNHANES) for the years 2011 and 2021. The subjects of the study were 5,350 people in 2011 and 4,687 people in 2021 aged 30 years and older. Analysis method was frequency analysis, complex samples Chi-square test, complex samples logistic regression analysis. Results : In 2011, the factors associated with stroke prevalence were gender, age, hypertension, dyslipidemia, diabetes, maternal diabetes, subjective health conditions, depressed more than 2 weeks, activity limitations, drinking, and Stress recognition. In 2021, the factors included age, hypertension, dyslipidemia, diabetes, paternal hyperlipidemia, maternal stroke, paternal diabetes, subjective health conditions, depressed more than 2 weeks, activity limitations, smoking present, and Stress recognition. Conclusion : To control the factors related to stroke prevalence, it is necessary to make active interventions for hypertension, dyslipidemia, and diabetes, such as medical treatment at healthcare institutions and individual treatment and preventive activities. Additionally, it is necessary to apply age-specific management programs, participate in health management programs, and receive psychological counseling to manage health related factors. Individuals, who have parental history of hypertension, stroke, hyperlipidemia, or diabetes, should receive selective screening and actively manage health behaviors and dietary habits in order to prevent stroke.

Purpose: : The purpose of this study is to identify the prevalence of stroke and related factors and thereby to provide fundamental data for the prevention and management of stroke. Methods : This study is a secondary analysis based on the raw data from the Korea National Health and Nutrition Examination Survey (KNHANES) for the years 2011 and 2021. The subjects of the study were 5,350 people in 2011 and 4,687 people in 2021 aged 30 years and older. Analysis method was frequency analysis, complex samples Chi-square test, complex samples logistic regression analysis. Results : In 2011, the factors associated with stroke prevalence were gender, age, hypertension, dyslipidemia, diabetes, maternal diabetes, subjective health conditions, depressed more than 2 weeks, activity limitations, drinking, and Stress recognition. In 2021, the factors included age, hypertension, dyslipidemia, diabetes, paternal hyperlipidemia, maternal stroke, paternal diabetes, subjective health conditions, depressed more than 2 weeks, activity limitations, smoking present, and Stress recognition. Conclusion : To control the factors related to stroke prevalence, it is necessary to make active interventions for hypertension, dyslipidemia, and diabetes, such as medical treatment at healthcare institutions and individual treatment and preventive activities. Additionally, it is necessary to apply age-specific management programs, participate in health management programs, and receive psychological counseling to manage health related factors. Individuals, who have parental history of hypertension, stroke, hyperlipidemia, or diabetes, should receive selective screening and actively manage health behaviors and dietary habits in order to prevent stroke.

No abstract available.
Cardiomyopathy, Dilated* ; Doxorubicin

PURPOSE: Cigarette smoking is associated not only with increased risk of cancer incidence, but also influences prognosis, and the quality of life of the cancer survivors. Thus, smoking cessation after cancer diagnosis is necessary. However, smoking behavior among Korean cancer-survivors is yet unknown. MATERIALS AND METHODS: We investigated the smoking status of 23770 adults, aged 18 years or older, who participated in the Health Interview Survey of the Korea National Health and Nutrition Examination Survey from 2007 to 2010. Data on the cancer diagnosis and smoking history were obtained from an interview conducted by trained personals. "Cancer-survivor" was defined as anyone who has been diagnosed with cancer by a physician regardless of time duration since diagnosis. Smoking status was classified into "never-smoker", "former-smoker", and "current-smoker". Former-smoker was further divided into "cessation before diagnosis" and "cessation after diagnosis". RESULTS: Overall, 2.1% of Korean adults were cancer-survivors. The smoking rate of Korean cancer-survivors was lower than that of non-cancer controls (7.8+/-1.3% vs. 26.4+/-0.4%, p<0.001). However, 53.4% of the cancer-survivors continued to smoke after their cancer diagnosis. In multivariate analysis, male gender [odds ratio (OR), 6.34; 95% confidence interval (CI), 2.62-15.31], middle-aged group (OR, 2.74; 95% CI, 1.12-6.72), the lowest income (OR, 4.10; 95% CI, 1.19-14.15), living with smoking family member(s) (OR, 5.49; 95% CI, 2.42-12.48), and the poor self-perceived health status (OR, 2.78; 95% CI, 1.01-7.71) were independently associated with persistent smoking among Korean cancer-survivors. CONCLUSION: The smoking rate among Korean cancer survivors is low. However, the smoking cessation rate after the cancer diagnosis is also low. This mandates comprehensive and systematic intervention for smoking cessation among cancer-survivors.
Adolescent ; Adult ; Aged ; Female ; Health Status ; Health Surveys ; Humans ; Incidence ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasms/chemically induced/*psychology ; Nutrition Surveys ; Odds Ratio ; Prevalence ; Prognosis ; *Quality of Life ; Republic of Korea/epidemiology ; Sex Distribution ; Smoking/*adverse effects/epidemiology/psychology ; Smoking Cessation/*psychology/statistics & numerical data ; Socioeconomic Factors ; Survivors/*psychology

Synovial sarcoma occurring in the pleura and lung is extremely rare. We report a case of pleuropulmonary synovial sarcoma as a second malignant neoplasm. The patient had been diagnosed with acute myelomonocytic leukemia at 5 years of age, and received matched sibling donor allogeneic bone marrow transplantation, with total body irradiation and cyclophosphamide conditioning. At 22 years of age, he complained of worsening chest discomfort and exertional dyspnea. Chest CT revealed a huge mass in the right middle lobe, pleura, and diaphragm. The patient was initially diagnosed as sarcomatoid malignant mesothelioma, without any environmental or occupational asbestos exposure. Five months later, the patient presented with soft tissue metastasis and underwent needle biopsy. Pathological examination including SYT-SSX RT-PCR revealed synovial sarcoma, which led to a review of the original tumor findings and confirmed the diagnosis of pleuropulmonary synovial sarcoma.To the best of our knowledge, our patient is the first case of pleuropulmonary synovial sarcoma developed after allogeneic hematopoietic stem cell transplantation.

Synovial sarcoma occurring in the pleura and lung is extremely rare. We report a case of pleuropulmonary synovial sarcoma as a second malignant neoplasm. The patient had been diagnosed with acute myelomonocytic leukemia at 5 years of age, and received matched sibling donor allogeneic bone marrow transplantation, with total body irradiation and cyclophosphamide conditioning. At 22 years of age, he complained of worsening chest discomfort and exertional dyspnea. Chest CT revealed a huge mass in the right middle lobe, pleura, and diaphragm. The patient was initially diagnosed as sarcomatoid malignant mesothelioma, without any environmental or occupational asbestos exposure. Five months later, the patient presented with soft tissue metastasis and underwent needle biopsy. Pathological examination including SYT-SSX RT-PCR revealed synovial sarcoma, which led to a review of the original tumor findings and confirmed the diagnosis of pleuropulmonary synovial sarcoma.To the best of our knowledge, our patient is the first case of pleuropulmonary synovial sarcoma developed after allogeneic hematopoietic stem cell transplantation.

Esophageal duplication is the congenital developmental anomaly manifestated as cystic or tubular type. The tubular esophageal duplication found at adult is extremely rare. A patient with tubular esophageal duplication is reported. A 37 years old male developed epigastric pain aggravated at hunger state from 2 monthes before administration. Gastrofiberscopy was done, and we could found the tubular esophageal duplication at 25 cm from incisiors. Esophagogram exposed the tunnel communicated with right anterior side of normal esophagus at upper and lower part of the tubular pathway with the length of 6 cm at T4-5 level. The microscopic finding of the tubular lumen revealed normal esophageal wall structure involving the outer part of muscle layer. Surgical resection was not done for the lesion was small and no symptom due to esophageal duplication was present. And so, the authors report this case as a tubular esophageal duplication with a literature review.
Adult ; Esophagus ; Humans ; Hunger ; Male